Access
To read this story in full you will need to login or make a payment (see right).
Nature Medicine 6, 228 (2000)
doi:10.1038/72347
On the market
Biodesign offers Scl-70 and autoimmune antigens for assay development. Studies have reported that the presence of autoantibodies against the Scl-70 antigen may have value as a specific serologic marker for research of systemic sclerosis.
To read this story in full you will need to login or make a payment (see right).
